Founding of a hospital focused on lung diseases
Shanghai's public institutional profile records the hospital's establishment in 1933 and its continuing clinical, teaching and research work in lung diseases.
Shanghai · Affiliated with Tongji UniversityPulmonary Hospital
Among the national top three for thoracic surgery reputation, advancing minimally invasive and precision lung surgery.
Founded in 1933, Shanghai Pulmonary Hospital ranked third in thoracic surgery and second in tuberculosis in the 2023 Fudan China Hospital Specialty Reputation Rankings. Its expertise extends beyond minimally invasive operations to technique and instrument development, pulmonary nodule consensus and intelligent early lung cancer care. Related projects led by Jiang Gening and Chen Chang received Shanghai Science and Technology Progress First Prizes for 2020 and 2025 respectively.
Shanghai, China
A focus on lung diseases, with nationally prominent specialties and original achievements
The hospital's long experience rests on a dedicated lung disease specialty system. National reputation rankings show the standing of thoracic surgery and tuberculosis; achievements in minimally invasive techniques, pulmonary nodule consensus and intelligent early lung cancer care demonstrate continuing progress from clinical challenges to innovation.
Beyond national standing, its specific strengths address key lung surgery questions: localization, reconstruction, nodule assessment and resection decisions.
National specialty standing and representative research honors
Rankings follow Fudan University's Hospital Management Institute 2023 China Hospital Specialty Reputation Rankings, published in November 2024.
Thoracic surgeryNo. 3 nationally
2023 Fudan China Hospital Specialty Reputation Rankings
TuberculosisNo. 2 nationally
2023 Fudan China Hospital Specialty Reputation Rankings
Minimally invasive and intelligent lung surgeryShanghai Science and Technology Progress First Prize
2020 key minimally invasive techniques; 2025 intelligent early lung cancer care
Rankings measure hospital specialty reputation. Science awards refer to specified research achievements and award years, rather than individual patient outcomes.
Thoracic surgery and tuberculosis both among national reputation leaders
The 2023 Fudan China Hospital Specialty Reputation Rankings placed thoracic surgery third and tuberculosis second. Strong positions in two distinct disciplines reflect the hospital's accumulated lung disease expertise, beyond any single surgical technique.
Shanghai First Prize for key minimally invasive lung surgery techniques
Jiang Gening's team received the 2020 Shanghai Science and Technology Progress First Prize for work involving uniportal thoracoscopic instruments, lung lesion localization and complex pulmonary artery and bronchial reconstruction. Its contribution lies in repeatedly solving specific challenges in minimally invasive surgery.
Another First Prize for intelligent early lung cancer care
Chen Chang led the project on key innovations and clinical applications in intelligent diagnosis and treatment of early lung cancer, which received the 2025 Shanghai Science and Technology Progress First Prize. Tongji University announced the award in July 2026. The work extends multimodal lung disease research into precise assessment and surgical decision-making.
Contributing to consensus on pulmonary ground-glass nodules
Jiang Gening and Chen Chang contributed to the Shanghai Expert Consensus on the Management of Pulmonary Ground-Glass Nodules, with Jiang as corresponding author. It connects imaging, pathology and management questions in a specialist discussion framework.
Shanghai Science and Technology First Prize for minimally invasive lung surgery
Jiang Gening's team received the 2020 Shanghai Science and Technology Progress First Prize for developing, applying and disseminating key minimally invasive lung surgery techniques. The award report appeared in 2021.
Shanghai Science and Technology First Prize for intelligent early lung cancer care
Chen Chang's early lung cancer intelligent care project received the 2025 Shanghai Science and Technology Progress First Prize, formally announced in July 2026.
Leading specialties,
built on medical achievements.
Explore Pulmonary Hospital's contributions in each field, from specialty standing to notable achievements, and the conditions this expertise supports.
No. 3 nationally in thoracic surgery
2023 Fudan China Hospital Specialty Reputation Rankings; ranking of the hospital's thoracic surgery discipline.
Its top-three thoracic surgery reputation is supported by traceable achievements: the 2018 ground-glass nodule consensus, minimally invasive techniques recognized in 2020, and intelligent early lung cancer care recognized in 2025. This expertise connects lesion identification, surgical planning and complex reconstruction.
Minimally invasive advances in instruments, localization and complex reconstruction
2020 · Shanghai Science and Technology Progress First PrizeJiang Gening's award-winning work includes uniportal surgical instruments, lung lesion localization and pulmonary artery and bronchial reconstruction, addressing technical challenges in complex lung surgery.
Key intelligent technologies for early lung cancer care
2025 · Shanghai Science and Technology Progress First PrizeChen Chang's project received First Prize. Tongji University's 2026 award announcement identifies both the project and its leader, demonstrating research connecting intelligent care technologies with clinical application.
Contributing to standards for pulmonary ground-glass nodule management
2018 · Expert consensusJiang Gening and Chen Chang co-authored the Shanghai expert consensus, discussing imaging, pathology and clinical management of ground-glass nodules, a common but complex assessment problem.
Multimodal care and medical-engineering collaboration
Chen Chang's team conducts collaborative work on multimodal lung disease care. Its institutional introduction records development of products including an AI early lung cancer screening system and 3D-printed lung puncture guides.
Expertise in lung cancer, airways and complex thoracic surgery
Jiang Gening's institutional profile covers lung cancer, lung transplantation, tracheal and mediastinal diseases and professional books on lung surgery and transplantation, reflecting a broad scope of complex thoracic expertise.
What conditions can this expertise help address?
Assessment of pulmonary nodules and lung cancer brings together serial imaging, available pathology and individual lung function. Precision lung surgery considers not only resectability but also resection extent and preservation of lung tissue. Existing records help the hospital identify the appropriate assessment pathway.
Meet the specialists
through their achievements.
Discover the specialists' contributions and the conditions and treatments they focus on.
Showing 2 representative specialists
Jiang Gening
Thoracic surgery: pulmonary nodules and precision lung surgery
Chief physician · Professor
Leader of a First Prize-winning minimally invasive lung surgery team
Ask about this doctorLeading award-winning minimally invasive lung surgery and serving as corresponding author of ground-glass nodule consensus
Jiang Gening's expertise includes lung cancer, lung transplantation, tracheal and mediastinal diseases. His team's minimally invasive work spans instruments, localization and reconstruction. He also contributes to pulmonary nodule consensus and professional books on lung surgery and transplantation, connecting surgical practice with standards.
The team's minimally invasive work received the 2020 Shanghai Science and Technology Progress First Prize
The project on development, clinical application and dissemination of key minimally invasive lung surgery techniques produced advances from instruments and localization to complex reconstruction. Tongji University's 2021 report specifically describes Jiang Gening's team's work.
Corresponding author of the 2018 Shanghai ground-glass nodule consensus
He contributed to and served as corresponding author of the consensus, advancing professional exchange and standards around a major clinical question in lung surgery.
Conditions and treatment expertise
- Lung cancer and minimally invasive lung surgery
- His clinical scope includes lung cancer surgery, lung lesion localization, uniportal minimally invasive procedures and complex pulmonary artery and bronchial reconstruction.
- Tracheal and mediastinal disease and lung transplant assessment
- His institutional supervisor profile lists tracheal disease, mediastinal disease and lung transplantation. These complex problems require a dedicated team to review imaging, previous treatment and overall health before defining the assessment pathway.
Chen Chang
Thoracic surgery: pulmonary nodules and precision lung surgery
Chief physician · Professor
Leader of a First Prize-winning intelligent early lung cancer care project
Ask about this doctorLeading an intelligent early lung cancer care project awarded Shanghai's Science and Technology Progress First Prize
Chen Chang has long researched thoracic surgery and multimodal care for lung diseases. His team brings medicine and engineering together in image recognition, lung localization and early lung cancer surgery. Its 2025 award-winning work further focuses on key intelligent care technologies and their clinical application.
Leading award-winning intelligent early lung cancer care research
The project on key technological innovations and clinical application in intelligent early lung cancer care received the 2025 Shanghai Science and Technology Progress First Prize. Tongji University's science and technology institute announcement identifies Chen Chang as project leader.
Contributing to the 2018 Shanghai ground-glass nodule consensus
As a co-author, he connected his lung disease research with the development of standards for nodule assessment, diagnosis and management.
Conditions and treatment expertise
- Pulmonary nodule assessment and early lung cancer evaluation
- His research covers multimodal lung disease care, including team work on image recognition, AI early lung cancer screening and lung puncture localization techniques.
- Early lung cancer surgery and minimally invasive surgery
- His clinical work covers thoracic surgery and uniportal thoracoscopy. His team studies surgical approaches for early lung cancer, emphasizing the relationship between lesion characteristics and operative plans.
These profiles describe professional expertise and notable experience. The doctor, campus and appointment time are confirmed when arranging care.
Want to learn about Pulmonary Hospital?
Contact us directly.
Tell eastmedgo about the specialty, doctor or care question that matters to you, through WhatsApp or email.
Initial service inquiries are free. Medical assessments and treatment recommendations are provided by the receiving hospital and doctors.
Related reading
Medical guides related to this hospital’s specialties.
Thoracic surgery: pulmonary nodules and precision lung surgery
Has a Ground-Glass Nodule Grown? Reviewing CT Images in Shanghai
Understand why original serial CT images, the solid component and scan comparability matter before deciding what a ground-glass nodule needs next.
Read articleNSCLC Molecular Reports: Preparing a Treatment Review in Shanghai
Prepare a meaningful Shanghai lung cancer review by linking the exact molecular result to pathology, stage, sample quality and treatment history.
Read article